US 11407825
NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof
granted A61KA61K47/59A61K47/68031
Quick answer
US patent 11407825 (NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof) held by Mersana Therapeutics, Inc. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K47/59, A61K47/68031, A61K47/6851, A61K47/6869